| Apr 26, 2006 |
Washington Business Journal: MedImmune to invest in N.J. biotech |
|
|
| Apr 26, 2006 |
Washington Post: Drug Firms' Deals Allowing Exclusivity |
|
|
| Apr 26, 2006 |
Medical-News.net: Protein mutated in cancer found to be linked to diabetes |
|
|
| Apr 26, 2006 |
KGBT-TV (TX): Study suggests money influences federal drug advisory panel voting |
|
|
| Apr 26, 2006 |
Industry Week: St. Louis: Gateway For New Medicines |
|
|
| Apr 26, 2006 |
The Age (Australia): Warning on reining in health care costs |
|
|
| Apr 26, 2006 |
Trading Markets: Wyeth Issues Statement On Petition Filed With FDA Related To Bio-identical Hormone Replacement Therapies |
|
|
| Apr 24, 2006 |
CBS News: Report: Drug Oversight Needs Work |
|
|
| Apr 17, 2006 |
West Central Tribune (MN): Addressing pharmacist shortage through innovation |
|
|
| Apr 17, 2006 |
The Age: Biotechnology 2006: there could be a fly in the ointment in Chicago |
|
|
| Apr 17, 2006 |
Press Release: New York's Biotechnology Sector Gains Momentum |
|
|
| Apr 17, 2006 |
Science & Technology News: Biotechnology thrives in India |
|
|
| Apr 17, 2006 |
DailyTech: Biotechnology Scientists Going Abroad in Search of Work |
|
|
| Apr 12, 2006 |
Austin Daily Herald (MN): Gaining access to cheaper prescriptions |
|
|
| Apr 12, 2006 |
Medical News Today: Are Pharmaceutical Companies Inventing Diseases, New Study Suggests They Are |
|
|
| Apr 12, 2006 |
Press Release: Product Re-Launch: Transforming Lackluster Pharmaceutical Products Into Market Success Stories |
|
|
| Apr 12, 2006 |
TradingMarkets.com: Teva Pharmaceutical Says FDA Denies Apotex's Request For Agency Determination For Pravastatin |
|
|
| Apr 12, 2006 |
The Independent (UK): Pharmaceutical groups defend record on drug prices for NHS |
|
|
| Apr 12, 2006 |
Chicago Sun-Times (IL): Biotechnology touted at Chicago conference |
|
|
| Apr 11, 2006 |
TradingMarkets.com: American Pharmaceutical Partners Gets FDA Approval For Its ANDA For Mitoxantrone Injection, USP |
|
|
| Apr 10, 2006 |
MercuryNews.com (MN): Stroke remedy showing promise |
|
|
| Apr 10, 2006 |
Business Week: Sanofi Aventis buys land for new facility |
|
|
| Apr 10, 2006 |
CNN: FDA backlog = Billions for Big Pharma? |
|
|
| Apr 10, 2006 |
Smartmoney.com: Serono Cancels Buyer Search, Eyes Deals |
|
|
| Apr 10, 2006 |
9News.com (CO): AARP: Brand-name drug prices shot past inflation |
|
|
| Apr 10, 2006 |
Bloomberg: Parexel Misled People Sickened by Test, Ethicists Say |
|
|
| Apr 10, 2006 |
ComputerWorld: Pharmaceutical company standardizes CRM |
|
|
| Mar 20, 2006 |
Press Release: TargetRx Unveils First Industry Analysis Linking Pharmaceutical Sales Force Effectiveness with Physician Prescribing |
|
|
| Mar 20, 2006 |
East Bay Business Times (CA): Viper's venom may help Emeryville biotech treat stroke |
|
|
| Mar 18, 2006 |
Pharmaceutical Manufacturing: MTC's Rich Kneece Featured in Pharma Manufacturing 2006 Job & Salary Survey |
|
|
| Feb 15, 2006 |
Press Release: Pharma Companies Look to R&D Operations in China to Secure a Future in the Chinese Health Care Market |
|
|
| Feb 15, 2006 |
Press Release: Biolex Therapeutics Presents Results Highlighting Benefits of Locteron at 'Breakthroughs in Hepatitis' Session |
|
|
| Feb 15, 2006 |
Press Release: New Targeted Treatment for Brain Tumors Shows Promise in Pre-Clinical Models |
|
|
| Feb 15, 2006 |
Press Release: Callisto's Cancer Drug Atiprimod to be Presented at Major Scientific Conference on Angiogenesis |
|
|
| Feb 15, 2006 |
Business Week: Genzyme swings to 4Q profit on less R&D |
|
|
| Feb 15, 2006 |
Palm Beach Post (FL): Web site to train new biotech workers |
|
|
| Jan 6, 2006 |
Boston Business Journal (MA): Repligen sues Bristol-Myers Squibb over drug patent |
|
|
| Jan 6, 2006 |
Press Release: Pfizer Introduces Radio Frequency Identification Technology to Combat Counterfeiting, Protect Patient Health |
|
|
| Jan 6, 2006 |
Press Release: Nobelist Discovers Antidepressant Protein in Mouse Brain |
|
|
| Jan 6, 2006 |
Press Release: Enzon Pharmceuticals to Return Rights to ATG-Fresenius S |
|
|
| Jan 6, 2006 |
MSNBC: Rhodia sells drugs unit to Shasun |
|
|
| Jan 6, 2006 |
Genetic Engineering News: A Company Review of Merck & Co, Covering, for Example, Their Current Status and Future Outlook |
|
|
| Dec 28, 2005 |
Press Release: Pfizer Takes 12% of Perlegen Sciences |
|
|
| Dec 28, 2005 |
Press Release: Targanta Acquires Late-Stage Antibiotic from InterMune |
|
|
| Dec 28, 2005 |
Smartmoney.com: Celgene Wins FDA Approval for Revlimid |
|
|
| Dec 28, 2005 |
News.com (Australia): Two top stem cell researchers lured to US |
|
|
| Dec 28, 2005 |
Forbes: Genentech on Forbes' Platinum list |
|
|
| Dec 28, 2005 |
MSNBC: AstraZeneca, Reloaded |
|
|
| Dec 28, 2005 |
Post-Gazette (PA): As biotech drug prices rise, U.S. hunts for solution |
|
|
| Dec 13, 2005 |
NY Newsday (NY): Voyager Pharmaceutical Withdraws IPO |
|
|
| Dec 13, 2005 |
Press Release: Allergan Welcomes Inamed's Recommendation of Its Offer to Stockholders |
|
|
| Dec 13, 2005 |
Press Release: NIH Launches Comprehensive Effort to Explore Cancer Genomics |
|
|
| Dec 13, 2005 |
Press Release: Diamyd Medical broadens diabetes pipeline with acquisition of Nurel Therapeutics |
|
|
| Dec 13, 2005 |
Press Release: Genzyme Uses Job Scheduler to Streamline BI for Financial Reporting |
|
|
| Dec 13, 2005 |
Associated Press: Palm Beach commissioners to examine Scripps split-campus plan |
|
|
| Nov 30, 2005 |
Press Release: GlaxoSmithKline Presents Rapidly Expanding Pipeline of Oncology and Supportive Care Compounds |
|
|
| Nov 26, 2005 |
Press Release: Depomed Announces Non-Binding Term Sheet Agreement With Biovail for Glumetza |
|
|
| Nov 26, 2005 |
Press Release: FDA Issues Approvable Letter For EPIX Pharmaceuticals Blood-Pool Contrast Agent Vasovist(TM); US Regulators Want Another Trial |
|
|
| Nov 26, 2005 |
Press Release: Jazz Pharmaceuticals, Inc. Release: Xyrem(R) Receives FDA Approval For The Treatment Of Excessive Daytime Sleepiness In Patients With Narcolepsy |
|
|
| Nov 26, 2005 |
Press Release: Tripos Gets $90 Million From Pfizer Inc. Collaboration |
|
|
| Nov 26, 2005 |
Press Release: Alexion Pharmaceuticals Inc. Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations |
|
|
| Nov 15, 2005 |
Press Release: Pfizer Inc.'s Torcetrapib/Atorvastatin Significantly Raised "Good" Cholesterol While Lowering "Bad" Cholesterol, New Data Show |
|
|
| Nov 15, 2005 |
Press Release: Celgene Receives Approvable Letter From FDA For THALOMID(R) In Treatment Of Newly Diagnosed Multiple Myeloma |
|
|
| Nov 15, 2005 |
Press Release: COPAXONE(R) Demonstrated Protection Against Neuronal Injury in Relapsing-Remitting Multiple Sclerosis |
|
|
| Nov 15, 2005 |
Press Release: Cerexa to Present at Credit Suisse First Boston Healthcare Conference |
|
|
| Nov 15, 2005 |
Press Release: PharmaFrontiers Reports Third Quarter 2005 Financial Results; Provides Update on Research & Development Activities |
|
|
| Nov 15, 2005 |
Press Release: MediGene's Drug Eligard Launched in Spain and Further European Countries |
|
|
| Nov 10, 2005 |
Press Release: Seizing the US Pharma Market: A Brand's Battle to the Top |
|
|
| Nov 10, 2005 |
Press Release: Ranbaxy wins on Atorvastatin process patent in Norway – Will appeal court ruling on intermediate compound patent |
|
|
| Nov 10, 2005 |
Press Release: Dynavax's TOLAMBA(TM) Demonstrates Safety in Phase 1 Trial of Ragweed Allergic Children |
|
|
| Nov 10, 2005 |
Press Release: Achieving Market Success: Thought Leaders Drive Success from Early Stage to Post-Launch |
|
|
| Nov 3, 2005 |
Press Release: Angiotech Pharmaceuticals (ANPI) Buys Graft Business For C$14 Million |
|
|
| Nov 3, 2005 |
Press Release: Celgene Corporation (CELG) Release: Clinical Data On Thalidomide Reported In Recurrent Epithelial Ovarian Cancer |
|
|
| Nov 3, 2005 |
Press Release: Court Denies Pfizer Inc.'s Summary Judgment Motion In Amlodipine Litigation With Mylan Pharmaceuticals, Inc. |
|
|
| Nov 3, 2005 |
Press Release: Investigator Presents Update on Phase III Nexavar(R) Trial in Patients with Advanced Kidney Cancer |
|
|
| Nov 3, 2005 |
Press Release: Merck Wins New Jersey VIOXX(R) Product Liability Case |
|
|
| Nov 3, 2005 |
Press Release: Abgenix And Amgen Announce Panitumumab Significantly Improves Progression-Free Survival In Phase 3 Randomized Metastatic Colorectal Cancer Study |
|
|
| Nov 3, 2005 |
Press Release: Novarits Exjade(R) Receives First Approval Worldwide In The U.S. |
|
|
| Nov 3, 2005 |
Press Release: Tarceva Now Approved for Advanced Non-Small Cell Lung Cancer and Pancreatic Cancer |
|
|
| Nov 3, 2005 |
Press Release: Biolex Therapeutics Announces Initiation of Phase 1 Clinical Study of Hepatitis C Candidate Locteron(TM) |
|
|
| Nov 3, 2005 |
Press Release: Enzon Reports First Quarter Results |
|
|
| Nov 3, 2005 |
Press Release: Ranbaxy Granted Permission to Appeal U.K. High Court Judgement on Patent Relating to Atorvastatin |
|
|
| Nov 3, 2005 |
Press Release: OPi receives marketing authorisation for Xenazine® 25 mg in France |
|
|
| Nov 3, 2005 |
Press Release: Biotech 2006 Set for May 22-23 in Winston-Salem |
|
|
| Nov 3, 2005 |
Press Release: Curis to Present at CIBC World Markets 16th Annual Healthcare Conference |
|
|
| Nov 3, 2005 |
Press Release: SeraCare Life Sciences to Present at the 16th Annual CIBC Healthcare Conference |
|
|
| Nov 3, 2005 |
Press Release: Medicure To Present At Biotech Investor Conference |
|
|
| Oct 28, 2005 |
Press Release: Chiron to Supply United States with Pandemic Influenza Vaccine for Stockpile |
|
|
| Oct 26, 2005 |
Press Release: Tanox, Inc. (TNOX) Reports Positive Results From Phase 2 Clinical Trial Of TNX-355, An Entry Inhibitor To Treat HIV |
|
|
| Oct 26, 2005 |
Press Release: Johnson & Johnson (JNJ) To Co-Develop Bayer Corporation (BAY)'s Key Thrombosis Drug |
|
|
| Oct 26, 2005 |
Press Release: Cerimon Pharmaceuticals Raises $70 Million In Series A Financing |
|
|
| Oct 26, 2005 |
Press Release: OXiGENE reports third-quarter 2005 operational and financial results |
|
|
| Oct 26, 2005 |
PR Newswire: Biolex Therapeutics Successfully Completes Phase 1 Study for First LEX System (TM) Produced Therapeutic Protein |
|
|
| Oct 18, 2005 |
Press Release: Bristol-Myers Squibb Company And Merck & Co., Inc. Say FDA Seeks More Data On Pargluva |
|
|
| Oct 18, 2005 |
Press Release: Genentech, Inc. Says Tarceva Doesn't Boost Avastin Effect |
|
|
| Oct 18, 2005 |
Press Release: GlaxoSmithKline's Havrix(R) (hepatitis A vaccine, inactivated) Now Approved For Use in Children Aged 12 Months and Older |
|
|
| Oct 18, 2005 |
Press Release: Novo Nordisk begins phase 1 study with rFXIII in cardiac surgery |
|
|
| Oct 18, 2005 |
Press Release: Galapagos Expands Its Collaboration with Serono |
|
|
| Oct 18, 2005 |
Press Release: Swedish Drug Development Company OxyPharma Starts Phase I Studies for RA Drug |
|
|
| Oct 18, 2005 |
Press Release: MediGene Honored with European Biotechnica Award |
|
|
| Oct 13, 2005 |
Press Release: Array BioPharma, Inc. (ARRY) And Genentech, Inc. (DNA) Expand Strategic Oncology Collaboration |
|
|
| Oct 13, 2005 |
Press Release: TRANSGENE Signs Agreement For The Production Of Innogenetics' Hepatitis B Therapeutic Vaccine Candidate |
|
|
| Oct 13, 2005 |
Press Release: Inspire Provides Update on Cystic Fibrosis Program; Moving Forward to Request End-of-Phase 2 Meeting with FDA |
|
|
| Oct 13, 2005 |
Press Release: Access Pharmaceuticals Restructures To Focus On Oncology Therapeutics; Oral Care Business Sold |
|
|
| Oct 12, 2005 |
Press Release: Area Life Science Companies Chosen to Make Presentations for Venture Funding at 2005 Mid-Atlantic Bio |
|
|
| Oct 12, 2005 |
Press Release: West Nile Vaccine Licensed by Hawaii Biotech |
|
|
| Oct 12, 2005 |
Press Release: Lilly ICOS Announces Positive Results from Phase 2 Study of Tadalafil in Treating Symptoms of Benign Prostatic Hyperplasia |
|
|
| Oct 11, 2005 |
Press Release: Accredo Health Inc. Announces Agreement To Acquire Specialty Pharmacy Business For Approximately $72 Million |
|
|
| Oct 11, 2005 |
Press Release: Alpharma Inc. Receives FDA Clearance To Initiate Phase II Clinical Trials For Abuse-Resistant, Extended-Release Opioid |
|
|
| Oct 11, 2005 |
Press Release: Antigenics Jumps On Phase 3 Melanoma Drug Data |
|
|
| Oct 11, 2005 |
Press Release: Praxis Recruitment Campaign Enrolls Rheumatoid Arthritis Study Two Months Early |
|
|
| Oct 10, 2005 |
Press Release: Genzyme licenses technology from UCLA and JNJ's Remicade Gets Expanded EU Approval |
|
|
| Oct 10, 2005 |
Press Release: Innate Pharma completes its management team with the recruitment of Dr. Patrick Squiban as Chief Medical Officer |
|
|
| Oct 10, 2005 |
Press Release: iCell Therapeutics Receives Support From the National Research Council's Industrial Research Assistance Program for Development of Cancer Treatment |
|
|
| Oct 10, 2005 |
Press Release: VIRA 38 Fraction (v38 AMF-1) Inhibits Bird Flu Virus (H5N1) Infections by Blocking Viral Attachment |
|
|
| Oct 10, 2005 |
Press Release: Agensys Signs Collaborative Research and License Agreement With sanofi pasteur |
|
|
| Oct 5, 2005 |
Press Release: North Carolina Biotechnology Center to dedicate new offices in Wilmington, Greenville |
|
|
| Oct 5, 2005 |
Press Release: Cambridge Antibody Technology Reports Recent Progress In Licensed Product Candidates |
|
|
| Oct 5, 2005 |
Press Release: Rib-X Granted Key Antibiotic Drug Discovery Patents |
|
|
| Oct 5, 2005 |
Press Release: Chemokine Therapeutics expands protection of core anti-cancer technology with issuance of new U.S. patent |
|
|
| Oct 5, 2005 |
Press Release: Shorter Course of PEG-INTRON(R) and REBETOL(R) Combination Therapy Approved in EU |
|
|
| Oct 5, 2005 |
Press Release: Provectus to Begin Clinical Trial on Breast Cancer |
|
|
| Oct 5, 2005 |
Press Release: Genzyme expands its research and manufacturing presence in Massachusetts |
|
|
| Oct 5, 2005 |
Press Release: USC Marshall School of Business to present European BioBusiness Leadership Award 2005 at CORDIA |
|
|
| Oct 5, 2005 |
Press Release: Bernard Siegel Receives 2005 Stem Cell Advocacy Award |
|
|
| Sep 29, 2005 |
Press Release: Pharming Expands Clinical Development Of Recombinant Human C1 Inhibitor For New Indications |
|
|
| Sep 29, 2005 |
Press Release: Active Biotech Presents Survival Data on Cancer Drug |
|
|
| Sep 29, 2005 |
PR Newswire: Provid Announces New National Cancer Institute Contract |
|
|
| Sep 29, 2005 |
Washington Post (DC): FDA Chief Wants Transformation in Medicine |
|
|
| Sep 29, 2005 |
Boston Globe (MA): FDA chief's resignation comes as surprise |
|
|
| Sep 29, 2005 |
Bio-IT World: Weekly IT and Informatics Product Roundup |
|
|
| Sep 29, 2005 |
Bio-IT World: FDA’s Gottlieb Blasts Importation and Calls for New Technology |
|
|
| Sep 27, 2005 |
Press Release: FDA Approves Pfizer's Lipitor(R) to Reduce Risk of Strokes and Heart Attacks in Patients With Diabetes |
|
|
| Sep 27, 2005 |
Press Release: RxHub Advances Electronic Prescribing Through Its Standards Approved By NCPDP and Its Partnership With Industry Leaders |
|
|
| Sep 27, 2005 |
Press Release: DOV Pharmaceutical, Inc. Announces Phase II Efficacy Results for One of its Novel Antidepressants, DOV 216,303 |
|
|
| Sep 27, 2005 |
Press Release: CuraGen and TopoTarget Initiate Phase Ib Clinical Trial with PXD101 for Advanced Colorectal Cancer |
|
|
| Sep 27, 2005 |
Press Release: PhRMA President Billy Tauzin Applauds Appointment of FDA Acting Commissioner |
|
|
| Sep 27, 2005 |
Press Release: Invitrogen to Present at UBS Global Life Sciences Conference |
|
|
| Sep 27, 2005 |
Press Release: Manhattan Research Reveals the Top 5 Traits of the 'Ideal' eDetail |
|
|
| Sep 27, 2005 |
Press Release: Biogen Idec and Elan Submit Supplemental Biologics License Application to the FDA for TYSABRI |
|
|
| Sep 23, 2005 |
Press Release: Vernalis signs new agreement with Diosynth Biotechnology for Phase III clinical trials |
|
|
| Sep 23, 2005 |
Press Release: Genzyme Opens New Discovery Research and Development Facility in Cambridge and Expands Manufacturing Site in Haverhill, UK |
|
|
| Sep 23, 2005 |
Press Release: Fisher Scientific to Present at UBS Global Life Sciences Conference |
|
|
| Sep 21, 2005 |
Chemical & Engineering News: Pharma, A Bright Spot In Hiring |
|
|
| Sep 19, 2005 |
Press Release: Parkinson's Patient Advocates Call on Amgen to Move Forward with GDNF Clinical Trials |
|
|
| Sep 19, 2005 |
Press Release: Viventia Receives FDA Clearance to Initiate Phase II Cancer Trial for Proxinium |
|
|
| Sep 19, 2005 |
Press Release: New Life Scientific signs Letter of Intent with CureLab, Inc. for long term agreement of Joint Development and Marketing Plan |
|
|
| Sep 19, 2005 |
Press Release: N.C. Bio Pharma Business Development Group changes name, expands reach |
|
|
| Sep 19, 2005 |
Press Release: Genentech Announces October 10 Webcast Discussion of Earnings and Other Business Results |
|
|
| Sep 15, 2005 |
Press Release: Missouri Governor Honored With Significant National Biotech Award |
|
|
| Sep 15, 2005 |
Press Release: PRA International Announces Partnership with Biomira Inc. |
|
|
| Sep 15, 2005 |
Press Release: FDA Commissioner Dr. Lester Crawford to Deliver Keynote Address at the Seventh Annual MASS Opportunities Biotechnology Investment Conference |
|
|
| Sep 15, 2005 |
Press Release: BioProcessors’ SimCell Platform Selected by Novo Nordisk |
|
|
| Sep 15, 2005 |
Press Release: Overcoming Adoption Challenges for Pharma Industry Highlighted at Patient-Level Data Conference |
|
|
| Sep 12, 2005 |
Press Release: Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin |
|
|
| Sep 12, 2005 |
PR Newswire: Peptides and Therapeutic Proteins Emerging as Attractive Drug Targets for the Pharmaceuticals Industry |
|
|
| Sep 12, 2005 |
Business Wire: SCOLR Pharma, Inc. Issued Second Patent for Platform Used to Formulate Challenging Drugs |
|
|
| Sep 7, 2005 |
Press Release: Protein Design Labs Phase 2 Ularitide Study Highlighted At European Society of Cardiology Congress |
|
|
| Sep 7, 2005 |
Press Release: AMBIEN CR(TM) CIV Receives FDA Approval For The Treatment Of Insomnia |
|
|
| Sep 7, 2005 |
Press Release: FDA Approves Vaccine to Help Protect Children Against Measles, Mumps, Rubella and Chickenpox in One Shot |
|
|
| Sep 7, 2005 |
Business Wire: Andrx Reports on FDA Developments |
|
|
| Sep 7, 2005 |
Business Wire: Chiron Responds to Novartis Offer |
|
|
| Sep 2, 2005 |
Press Release: Approvable Letter Received from the FDA for Dacogen(TM) (Decitabine) Injection for the Treatment of MDS |
|
|
| Aug 31, 2005 |
Press Release: Cost-effective R&D Outsourcing Attracts Global Pharmaceutical Industry to India and China |
|
|
| Aug 31, 2005 |
Press Release: Patient Recruitment Plays a Major Role in Meeting Clinical Trial Deadlines |
|
|
| Aug 31, 2005 |
Press Release: FDA Approves Tercica's Increlex for Short Stature Caused by Severe Primary IGF-1 Deficiency |
|
|
| Aug 31, 2005 |
Press Release: ImmunoGen, Inc. Announces that the sanofi-aventis Group Has Extended its Research Collaboration with the Company |
|
|
| Aug 29, 2005 |
Press Release: Par Pharmaceutical Receives Final Approval to Market Generic Questran(R) Powder and Questran(R) Light Powder for Oral Suspension |
|
|
| Aug 29, 2005 |
Press Release: California Attorney General Accuses Drug Companies of Fraud |
|
|
| Aug 29, 2005 |
Press Release: Invitrogen Signs Agreement with Nonlinear Dynamics to Distribute Advanced Analysis Software Solutions |
|
|
| Aug 26, 2005 |
Press Release: FDA Defers Decision on Plan B Over-the-Counter Application |
|
|
| Aug 26, 2005 |
Press Release: Encore Pharmaceuticals Receives Second 2005 SBIR Award |
|
|
| Aug 26, 2005 |
Press Release: DRAXIS Extends Scheduled Shutdown for Contract Manufacturing Division |
|
|
| Aug 26, 2005 |
Press Release: Pfizer expands SUTENT® (sunitinib malate) access program to patients with kidney cancer |
|
|
| Aug 24, 2005 |
Press Release: Amexdrug Corporation to Acquire Dermagen, Inc. |
|
|
| Aug 24, 2005 |
Press Release: Isis Pharmaceuticals Raises $51 Million in Private Offering |
|
|
| Aug 24, 2005 |
Press Release: Bioinformatics Market Surges Ahead |
|
|
| Aug 24, 2005 |
Press Release: Icoria to Conduct Biomarker Study for Isis Pharmaceuticals |
|
|
| Aug 24, 2005 |
Press Release: Eric Brandt to Be President and Chief Executive Officer of AVANIR Pharmaceuticals |
|
|
| Aug 22, 2005 |
Press Release: Operating Costs in Clinical Trials Force CROs to Work with EDC, Life Science Insights Finds |
|
|